BE883859A - Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant - Google Patents

Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant

Info

Publication number
BE883859A
BE883859A BE0/201060A BE201060A BE883859A BE 883859 A BE883859 A BE 883859A BE 0/201060 A BE0/201060 A BE 0/201060A BE 201060 A BE201060 A BE 201060A BE 883859 A BE883859 A BE 883859A
Authority
BE
Belgium
Prior art keywords
pyridylaminotriazoles
novel
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
BE0/201060A
Other languages
English (en)
Inventor
C Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE883859A publication Critical patent/BE883859A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/201060A 1979-06-18 1980-06-17 Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant BE883859A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/049,737 US4276297A (en) 1979-06-18 1979-06-18 Pyridylaminotriazole therapeutic agents

Publications (1)

Publication Number Publication Date
BE883859A true BE883859A (fr) 1980-12-17

Family

ID=21961428

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/201060A BE883859A (fr) 1979-06-18 1980-06-17 Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant

Country Status (24)

Country Link
US (1) US4276297A (fr)
JP (1) JPS565477A (fr)
KR (2) KR840002173B1 (fr)
AR (2) AR225766A1 (fr)
AT (2) AT375655B (fr)
BE (1) BE883859A (fr)
CA (1) CA1140133A (fr)
CH (1) CH644375A5 (fr)
DE (1) DE3022302C2 (fr)
DK (1) DK258180A (fr)
ES (2) ES8105313A1 (fr)
FI (1) FI69842C (fr)
FR (1) FR2459241A1 (fr)
GB (1) GB2053910B (fr)
GR (1) GR68731B (fr)
IE (1) IE49913B1 (fr)
IL (1) IL60332A (fr)
IT (1) IT1140993B (fr)
LU (1) LU82527A1 (fr)
NL (1) NL182641C (fr)
PH (1) PH16875A (fr)
PT (1) PT71399A (fr)
SE (1) SE441745B (fr)
YU (2) YU41717B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR230994A1 (es) * 1981-08-31 1984-08-31 Pfizer Procedimiento para preparar compuesto de 3'-substituido-5'-(2-amino-4-piridil)-1',2',4'-triazol
JP2518515Y2 (ja) * 1993-09-22 1996-11-27 茂郎 槇島 水虫用医療包帯
US9440953B2 (en) * 2014-12-19 2016-09-13 OncoArendi Therapeutics Sp. z o.o. Substituted amino triazoles useful as acidic mammalian chitinase inhibitors
EP4196793A1 (fr) 2020-08-11 2023-06-21 Université de Strasbourg Bloqueurs de h2 ciblant des macrophages du foie pour la prévention et le traitement d'une maladie du foie et du cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1925654U (de) 1965-07-23 1965-10-21 Alfons Mann Zusatzeinrichtung fuer vergaser an benzinmotoren zur steigerung der motorenleistung.
CH521419A (de) * 1968-03-01 1972-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Azofarbstoffe
GB1264798A (fr) 1968-07-10 1972-02-23
US3647814A (en) * 1969-07-03 1972-03-07 Rohm & Haas Method for preparing 4-substituted-1 2 4-triazoles
NL7112373A (fr) * 1970-09-25 1972-03-28
NL7112372A (fr) * 1970-09-25 1972-03-28
GB1403866A (en) * 1971-12-06 1975-08-28 Wyeth John & Brother Ltd Derivatives of 3-amino-1,2,4-triazoles
US3879404A (en) * 1972-07-07 1975-04-22 John J Baldwin Certain 5-(pyridyl)-3(phenyl)-1,2,4-triazoles
US3873563A (en) * 1972-09-29 1975-03-25 Sakai Chemical Industry Co Method for manufacturing 4-amino-1,2,4-triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles

Also Published As

Publication number Publication date
FI69842C (fi) 1986-05-26
PH16875A (en) 1984-04-02
JPS617426B2 (fr) 1986-03-06
NL182641C (nl) 1988-04-18
FI801929A (fi) 1980-12-19
FR2459241A1 (fr) 1981-01-09
DE3022302C2 (de) 1984-03-01
YU41536B (en) 1987-08-31
ES8201155A1 (es) 1981-12-01
YU263382A (en) 1983-04-30
FI69842B (fi) 1985-12-31
NL8003496A (nl) 1980-12-22
KR840002172B1 (ko) 1984-11-26
ATA307583A (de) 1984-01-15
CH644375A5 (fr) 1984-07-31
KR840002173B1 (ko) 1984-11-26
GB2053910B (en) 1983-04-20
PT71399A (en) 1980-07-01
DK258180A (da) 1980-12-19
JPS565477A (en) 1981-01-20
DE3022302A1 (de) 1981-01-08
ES498821A0 (es) 1981-12-01
IE49913B1 (en) 1986-01-08
CA1140133A (fr) 1983-01-25
YU158780A (en) 1983-04-30
ATA319280A (de) 1984-01-15
AR227436A1 (es) 1982-10-29
IL60332A0 (en) 1980-09-16
KR840004687A (ko) 1984-10-22
GB2053910A (en) 1981-02-11
IE801250L (en) 1980-12-18
SE441745B (sv) 1985-11-04
US4276297A (en) 1981-06-30
LU82527A1 (fr) 1981-02-03
AT375656B (de) 1984-08-27
YU41717B (en) 1987-12-31
NL182641B (nl) 1987-11-16
IT1140993B (it) 1986-10-10
IL60332A (en) 1983-09-30
KR830002756A (ko) 1983-05-30
GR68731B (fr) 1982-02-10
FR2459241B1 (fr) 1983-06-17
AT375655B (de) 1984-08-27
ES492522A0 (es) 1981-06-01
AR225766A1 (es) 1982-04-30
IT8022825A0 (it) 1980-06-17
ES8105313A1 (es) 1981-06-01
SE8004498L (sv) 1980-12-19

Similar Documents

Publication Publication Date Title
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
FR2345450A1 (fr) Quinoxalinones et quinoxalines, leurs procedes de preparation et composition pharmaceutique les contenant
BE870402A (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
BE876042A (fr) Nouvelles 4-(quinoleinylaminobenzoyl) piperidines et composition pharmaceutique les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
BE885709A (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE815584A (fr) Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant
BE883859A (fr) Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19890630